Integra LifeSciences IART Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$495.8M— | -$516.47M— | —— | —— | —— | ||
| $153.07M+3.8% | $151.83M+7.8% | $150.99M+12.4% | $148.43M+15.2% | $147.52M+20.0% | ||
| $21.88M+6.0% | $18.58M-23.8% | $19.9M-13.6% | $18.7M-22.4% | $20.65M-6.7% | ||
| $71.44M-30.2% | $50.38M-61.1% | $89.31M-35.0% | $70.89M-50.0% | $102.37M-21.0% | ||
| $67.36M-42.9% | $81.44M-22.0% | $93.82M-5.6% | $108.31M+30.8% | $117.87M+71.8% | ||
| -$86.99M+76.7% | -$108.06M+72.3% | -$77.41M+82.6% | -$72.21M+83.6% | -$372.76M-177% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Integra LifeSciences generate?
- Integra LifeSciences (IART) generated $71.4M in operating cash flow over the trailing twelve months.
- What is Integra LifeSciences's free cash flow?
- After $67.4M of capital expenditures, Integra LifeSciences's free cash flow was -$61.8M over the trailing twelve months, down 193.2% year over year.
- Where does Integra LifeSciences's cash flow data come from?
- Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
